Bilateral reversible corneal edema associated with amantadine use

Journal of Ocular Pharmacology and Therapeutics

Volumn 25, Issue 6, 2009, Pages 567-569

  Esquenazi, Salomon ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Rand Eye Institute   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMFEBUTAMONE; CLONAZEPAM; FLUOXETINE; GLATIRAMER; PREDNISOLONE ACETATE; TOPIRAMATE;

ADULT; ANOREXIA NERVOSA; ANTERIOR EYE CHAMBER; ANTERIOR EYE CHAMBER ANGLE; ARTERY CLAMP; ARTICLE; BRAIN ARTERY ANEURYSM; CASE REPORT; CELL COUNT; CORNEA EDEMA; CORNEA ENDOTHELIUM; CORNEA STROMA; CORNEA THICKNESS; CORTICOSTEROID THERAPY; DESCEMET MEMBRANE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOTHELIUM CELL; EYE EXAMINATION; FATIGUE; FEMALE; HEAD INJURY; HUMAN; LENS; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUTRITIONAL DEFICIENCY; OPTIC NEURITIS; PERIMETRY; SEIZURE; SKULL FRACTURE; SPECULAR MICROSCOPY; TREMOR; VISUAL ACUITY; VISUAL IMPAIRMENT;

ADULT; AMANTADINE; CORNEA; CORNEAL EDEMA; DIAGNOSIS, DIFFERENTIAL; DOPAMINE AGENTS; FEMALE; HUMANS; SEVERITY OF ILLNESS INDEX; VISUAL ACUITY;

EID: 77149160016     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2009.0029     Document Type: Article

References (12)

1. Boerio, D., Lefaucher, J.P., Hogrel, J.Y., et al. Pathophysiology and treatment of fatigue in Multiple Sclerosis. Rev. Neurol. 162:311-320, 2006.
2. Hughes, B., Flynn, S.B., and Brodsky, M.C. Reversible amantadine- induced corneal edema in an adolescent. Cornea. 23:823-824, 2004.
3. Jeng, B.H., Galor, A., Lee, M.S., et al. Amantadine associated corneal edema potentially irreversible even after cessation of the medication. Ophthalmology. 115:1540-1544, 2008.
4. Naumann, G.O., and Schlotzer-Schrehardt, U. Amantadineassociated corneal edema. Ophthalmology. 116:1230-1231, 2009.
5. Pond, A., Lee, M.S., Hardten, D.R., et al. Toxic corneal oedema associated with amantadine use. Br. J. Ophthalmol. 93:281, 2009.
6. Dubow, J.S., Rezak, M., and Berman, A.A. Reversible corneal edema associated with amantadine use: an unrecognized problem. Mov. Disord. 23:2096-2097, 2008.
7. Hadjikoutis, S., Morgan, J.E., Wild, J.M., et al. Ocular complications of neurological therapy. Eur. J. Neurol. 12:499-507, 2005.
8. Nakamagoe, K., Ohkoshi, N., Fugita, T., et al. Keratitis and corneal edema associated with levodopa use- a case report. Rinsho. Shinkeigaku. 36:886-888, 1996.
9. Waring, G.O. III. Posterior collagenous layer of the cornea: ultrastructural classification of abnormal collagenous tissue posterior to Descemet's membrane in 30 cases. Arch Ophthalmol. 100:122-134, 1982.
10. Kerimoglu, H., Tokgoz, M., Ozturk, B., et al. Topiramate induced acute-onset myopia and central corneal thickening: Pentacam Scheimpflug imaging findings. Can. J. Ophthalmol. 44:222-223, 2009.
11. Hara, E., Reinach, P.S., Wen, Q., et al. Fluoxetine inhibits K transport pathways underlying volume regulation in corneal endothelial cells. J. Membr. Biol. 171:75-85, 1999.
12. Chang, K.C., Kim, M.K., Wee, W.R., et al. Corneal endothelial dysfunction associated with amantadine toxicity. Cornea. 27:1182-1185, 2008.